| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |